ADMA Biologics manufactures FDA-approved biologics.
5 reports, 2 independent
Updated Jul 29
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 3
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ADMA Biologics manufactures FDA-approved biologics.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- ASCENIV is identified as ADMA Biologics' flagship immunoglobulin product.Sub-event
ADMA Biologics has received FDA approval for its biologics.1 source
FDA approval supports production yields for ADMA Biologics.1 source
Keep exploring
The entities involved
- FDA
-
ADMA Biologics (United States)
company in Ramsey, United States
Nothing else this week.
Related events
- FDA approved a new cancer drug in Massachusetts on October 21, 2026.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- Generic medicine services are seeking approval for launch from the FDA.
Coverage
Newest first; wire copies grouped- GlobeNewswireADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., July 30, 2025 (GLOBE
- Simply Wall St.High Growth Tech Stocks In The US To Watch This July 2025 The United States market has experienced a 1.4% increase over the past week and is up 17% over the last year, with earnings anticipated to gr
- Unknown outlet
- Unknown outlet